In a mouse model of rheumatoid arthritis (RA), pharmacological inhibition of CatS led to a decrease in disease progression and disease scoring, suggesting a potential positive effect in targeting CatS in RA [32]. This evidence concerns the gene PIMREG and rheumatoid arthritis.